4//SEC Filing
Taylor Andrew Lawrence 4
Accession 0001104659-25-075789
CIK 0001814114other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 7:18 PM ET
Size
5.5 KB
Accession
0001104659-25-075789
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-08-07+80,000→ 480,788 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs") to the Reporting Person on August 7, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001723889
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 7:18 PM ET
- Size
- 5.5 KB